ShipStation® Improves Fulfilment Efficiency for UK Businesses With Enhanced Platform Capabilities November 18, 2025 UK merchants can now seamlessly manage shipping operations with new inventory and analytics solutions, flexible plans including a free option, and product advancements
European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab November 18, 2025 Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab has been approved by the European Commission (EC) for all previously approved indications for Remsima™ IV powder formulation1 The approval is based on the comparability data between infliximab powder formulation and the liquid formulation2 The new liquid formulation of infliximab, available in 100 mg and a newly introduced 350 mg presentation, eliminates the need for reconstitution and cuts drug preparation time by 51%, lowering preparation costs by 20% 1,3 Projected annual cost savings across seven European countries could reach up to €2.6 million, alongside significant improvements to workflow efficiency 3
Finimize and Charles Schwab to Deliver Educational Investment Content to International Investors November 18, 2025 Multi-channel campaign will provide customised educational guides and webinars for retail investors
Beyond by RS2 Becomes a Principal Issuing Member of Visa November 18, 2025 Beyond by RS2, the innovation brand of RS2 Financial Services GmbH, has become a Principal Issuing Member of Visa in Europe – allowing the company to directly issue Visa cards and to launch and manage payment card programs. With this milestone, Beyond by RS2 strengthens its position as an end-to-end payment partner, combining issuing, acquiring, [...]
Celltrion Announces European Commission Approval of Additional Line Extension for Omlyclo™ 300mg November 18, 2025 Omlyclo™ (omalizumab) is the first and only omalizumab biosimilar approved in Europe Omlyclo™ 300 mg/2ml prefilled syringe (PFS) presentation is now approved in EU offering a simpler dosing schedule and improved patient adherence
Duravant Announces Retirement of CEO Mike Kachmer, Names Jill Evanko Successor November 17, 2025 Mike Kachmer to retire following a distinguished 43-year career, including nearly 12 years as Chairman & CEO of Duravant Jill Evanko to succeed Mr. Kachmer as Duravant’s Chief Executive Officer
Terra Firma Energy Completes Pre-Emptive Maintenance Programme to Support UK Grid Through Early Winter Demand Surge November 17, 2025 Terra Firma Energy (TFE), a leading owner and operator of flexible generation assets, today announces the completion of a fleet-wide programme of pre-emptive maintenance to ensure maximum availability and resilience ahead of what is expected to be a challenging winter for the UK electricity system. This announcement follows the amber cold-weather health alert issued by [...]
Gen Z Swaps Coffee for Cocktails November 17, 2025 18-29 year-olds are driving the growth of cocktail culture in the UK according to the 2026 Bacardi Cocktail Trends Report
87% of Institutional Investors Have Declined or Reconsidered Fund Commitments Due to AML/KYC Concerns November 17, 2025 63% of GPs say they have lost investors or reinvestments due to AML/KYC compliance shortcomings 88% of LPs are more likely to invest in a manager with a formal AML/KYC program Nearly three-quarters of GPs report cost savings of 10-30% from outsourcing AML/KYC functions to dedicated specialists
World First: Autonomous Racing Leaps Forward in Abu Dhabi as A2RL Season 2 Showcases Record Speed, Bold Overtakes and Real-Time AI Decision-Making November 17, 2025 TUM Retains Crown as A2RL Delivers World’s First Six-Car Autonomous Grand Final Eleven international teams competed for $2.25 million prize pool Human vs AI: Former F1 star Daniil Kvyat stayed just ahead of the autonomous challenger’s time; for now, human drivers still hold a slight edge Watch the race here: https://youtu.be/d9LLZ5mb5cA?si=RgJnvjWhdasZdXZS